|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 47/38 | |
| A61K 9/28 | |||
| A61K 31/573 | |||
| A61P 5/44 |
| (11) | Number of the document | 2416783 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10712907.4 |
| Date of filing the European patent application | 2010-04-07 | |
| (97) | Date of publication of the European application | 2012-02-15 |
| (45) | Date of publication and mention of the grant of the patent | 2018-11-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2010/002178 |
| Date | 2010-04-07 |
| (87) | Number | WO 2010/115615 |
| Date | 2010-10-14 |
| (30) | Number | Date | Country code |
| 200900470 | 2009-04-07 | DK |
| (72) |
LENNERNÄS, Hans, SE
JOHNSSON, Jörgen, SE
HEDNER, Thomas, SE
JOHANNSSON, Gudmundur, SE
SKRTIC, Stanko, SE
|
| (73) |
Shire Viropharma Incorporated,
300 Shire Way, Lexington, MA 02421,
US
|
| (54) | IMPROVED GLUCOCORTICOID THERAPY |
| IMPROVED GLUCOCORTICOID THERAPY |